Copeptin: Utility in Paediatric Patients with Hyponatraemia

Introduction: Copeptin concentrations are a useful component of the diagnostic workup of paediatric patients with polyuria and polydipsia, but the value of measuring copeptin in patients with hyponatraemia is less clear. Case Reports: We report 5 children with hyponatraemia in the context of differe...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Hormone research in paediatrics 2022-05, Vol.95 (1), p.82-87
Hauptverfasser: Boal, Rachel L., Hughes, James, Matthews, Debbie, Johnstone, Helen, Boot, Christopher, Cheetham, Tim D.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 87
container_issue 1
container_start_page 82
container_title Hormone research in paediatrics
container_volume 95
creator Boal, Rachel L.
Hughes, James
Matthews, Debbie
Johnstone, Helen
Boot, Christopher
Cheetham, Tim D.
description Introduction: Copeptin concentrations are a useful component of the diagnostic workup of paediatric patients with polyuria and polydipsia, but the value of measuring copeptin in patients with hyponatraemia is less clear. Case Reports: We report 5 children with hyponatraemia in the context of different underlying pathologies. Copeptin concentrations were elevated in 4 cases (13.7, 14.4, 26.1, and 233 pmol/L; reference range 2.4–8.6 pmol/L), suggesting that non-osmoregulated vasopressin release (syndrome of inappropriate antidiuretic hormone) was the underlying mechanism for low sodium levels. In one of the patients, there was an underlying diagnosis of Schaaf-Yang syndrome (MAGEL2 gene mutation) with a clinical picture suggestive of dysregulated vasopressin production with inappropriately high and then low copeptin release. In one hyponatraemic patient, low copeptin concentrations indicated that non-osmoregulated arginine vasopressin release was not the cause of hyponatraemia and oliguria. Discussion: Copeptin measurement did not influence management acutely but helped to clarify the mechanism leading to hyponatraemia when the result was available. Relatively high and low copeptin concentrations in association with hypo- and hypernatraemia indicate dysregulated vasopressin production in Schaaf-Yang syndrome.
doi_str_mv 10.1159/000521073
format Article
fullrecord <record><control><sourceid>pubmed_karge</sourceid><recordid>TN_cdi_pubmed_primary_34814150</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>34814150</sourcerecordid><originalsourceid>FETCH-LOGICAL-c301t-a198d8cc56334eb57157f98cb48c01fb7913d95792783df3030b51cc1227d7ec3</originalsourceid><addsrcrecordid>eNptkM1LxDAQxYMo7rLuwbtIwZOHaqZpmkRPS1FXWHAR91zSNNXo9oMkIv3vjVR78jQP3m-GNw-hU8BXAFRcY4xpApiRAzSHLCNxwpPscNLAZ2jp3HvAMOFMADtGM5JySIHiObrNu1733rQ30c6bvfFDZNpoK3VlpLdGBemNbr2Lvox_i9ZD37XBkLox8gQd1XLv9PJ3LtDu_u4lX8ebp4fHfLWJFcHgYwmCV1wpmhGS6pIyoKwWXJUpVxjqMmQilaBMJIyTqiaY4JKCUpAkrGJakQW6HO8q2zlndV301jTSDgXg4qeDYuogsOcj23-Wja4m8u_jAJyNwIe0r9pOwLR_8a-9ft6ORNGHiN-R7GnZ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Copeptin: Utility in Paediatric Patients with Hyponatraemia</title><source>Karger Journals Complete</source><source>Alma/SFX Local Collection</source><creator>Boal, Rachel L. ; Hughes, James ; Matthews, Debbie ; Johnstone, Helen ; Boot, Christopher ; Cheetham, Tim D.</creator><creatorcontrib>Boal, Rachel L. ; Hughes, James ; Matthews, Debbie ; Johnstone, Helen ; Boot, Christopher ; Cheetham, Tim D.</creatorcontrib><description>Introduction: Copeptin concentrations are a useful component of the diagnostic workup of paediatric patients with polyuria and polydipsia, but the value of measuring copeptin in patients with hyponatraemia is less clear. Case Reports: We report 5 children with hyponatraemia in the context of different underlying pathologies. Copeptin concentrations were elevated in 4 cases (13.7, 14.4, 26.1, and 233 pmol/L; reference range 2.4–8.6 pmol/L), suggesting that non-osmoregulated vasopressin release (syndrome of inappropriate antidiuretic hormone) was the underlying mechanism for low sodium levels. In one of the patients, there was an underlying diagnosis of Schaaf-Yang syndrome (MAGEL2 gene mutation) with a clinical picture suggestive of dysregulated vasopressin production with inappropriately high and then low copeptin release. In one hyponatraemic patient, low copeptin concentrations indicated that non-osmoregulated arginine vasopressin release was not the cause of hyponatraemia and oliguria. Discussion: Copeptin measurement did not influence management acutely but helped to clarify the mechanism leading to hyponatraemia when the result was available. Relatively high and low copeptin concentrations in association with hypo- and hypernatraemia indicate dysregulated vasopressin production in Schaaf-Yang syndrome.</description><identifier>ISSN: 1663-2818</identifier><identifier>EISSN: 1663-2826</identifier><identifier>DOI: 10.1159/000521073</identifier><identifier>PMID: 34814150</identifier><language>eng</language><publisher>Basel, Switzerland</publisher><subject>Novel Insights from Clinical Practice / Case Report</subject><ispartof>Hormone research in paediatrics, 2022-05, Vol.95 (1), p.82-87</ispartof><rights>2021 S. Karger AG, Basel</rights><rights>2021 S. Karger AG, Basel.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c301t-a198d8cc56334eb57157f98cb48c01fb7913d95792783df3030b51cc1227d7ec3</citedby><cites>FETCH-LOGICAL-c301t-a198d8cc56334eb57157f98cb48c01fb7913d95792783df3030b51cc1227d7ec3</cites><orcidid>0000-0002-4234-8545 ; 0000-0003-3120-2513</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,2429,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34814150$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Boal, Rachel L.</creatorcontrib><creatorcontrib>Hughes, James</creatorcontrib><creatorcontrib>Matthews, Debbie</creatorcontrib><creatorcontrib>Johnstone, Helen</creatorcontrib><creatorcontrib>Boot, Christopher</creatorcontrib><creatorcontrib>Cheetham, Tim D.</creatorcontrib><title>Copeptin: Utility in Paediatric Patients with Hyponatraemia</title><title>Hormone research in paediatrics</title><addtitle>Horm Res Paediatr</addtitle><description>Introduction: Copeptin concentrations are a useful component of the diagnostic workup of paediatric patients with polyuria and polydipsia, but the value of measuring copeptin in patients with hyponatraemia is less clear. Case Reports: We report 5 children with hyponatraemia in the context of different underlying pathologies. Copeptin concentrations were elevated in 4 cases (13.7, 14.4, 26.1, and 233 pmol/L; reference range 2.4–8.6 pmol/L), suggesting that non-osmoregulated vasopressin release (syndrome of inappropriate antidiuretic hormone) was the underlying mechanism for low sodium levels. In one of the patients, there was an underlying diagnosis of Schaaf-Yang syndrome (MAGEL2 gene mutation) with a clinical picture suggestive of dysregulated vasopressin production with inappropriately high and then low copeptin release. In one hyponatraemic patient, low copeptin concentrations indicated that non-osmoregulated arginine vasopressin release was not the cause of hyponatraemia and oliguria. Discussion: Copeptin measurement did not influence management acutely but helped to clarify the mechanism leading to hyponatraemia when the result was available. Relatively high and low copeptin concentrations in association with hypo- and hypernatraemia indicate dysregulated vasopressin production in Schaaf-Yang syndrome.</description><subject>Novel Insights from Clinical Practice / Case Report</subject><issn>1663-2818</issn><issn>1663-2826</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNptkM1LxDAQxYMo7rLuwbtIwZOHaqZpmkRPS1FXWHAR91zSNNXo9oMkIv3vjVR78jQP3m-GNw-hU8BXAFRcY4xpApiRAzSHLCNxwpPscNLAZ2jp3HvAMOFMADtGM5JySIHiObrNu1733rQ30c6bvfFDZNpoK3VlpLdGBemNbr2Lvox_i9ZD37XBkLox8gQd1XLv9PJ3LtDu_u4lX8ebp4fHfLWJFcHgYwmCV1wpmhGS6pIyoKwWXJUpVxjqMmQilaBMJIyTqiaY4JKCUpAkrGJakQW6HO8q2zlndV301jTSDgXg4qeDYuogsOcj23-Wja4m8u_jAJyNwIe0r9pOwLR_8a-9ft6ORNGHiN-R7GnZ</recordid><startdate>20220501</startdate><enddate>20220501</enddate><creator>Boal, Rachel L.</creator><creator>Hughes, James</creator><creator>Matthews, Debbie</creator><creator>Johnstone, Helen</creator><creator>Boot, Christopher</creator><creator>Cheetham, Tim D.</creator><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><orcidid>https://orcid.org/0000-0002-4234-8545</orcidid><orcidid>https://orcid.org/0000-0003-3120-2513</orcidid></search><sort><creationdate>20220501</creationdate><title>Copeptin: Utility in Paediatric Patients with Hyponatraemia</title><author>Boal, Rachel L. ; Hughes, James ; Matthews, Debbie ; Johnstone, Helen ; Boot, Christopher ; Cheetham, Tim D.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c301t-a198d8cc56334eb57157f98cb48c01fb7913d95792783df3030b51cc1227d7ec3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Novel Insights from Clinical Practice / Case Report</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Boal, Rachel L.</creatorcontrib><creatorcontrib>Hughes, James</creatorcontrib><creatorcontrib>Matthews, Debbie</creatorcontrib><creatorcontrib>Johnstone, Helen</creatorcontrib><creatorcontrib>Boot, Christopher</creatorcontrib><creatorcontrib>Cheetham, Tim D.</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><jtitle>Hormone research in paediatrics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Boal, Rachel L.</au><au>Hughes, James</au><au>Matthews, Debbie</au><au>Johnstone, Helen</au><au>Boot, Christopher</au><au>Cheetham, Tim D.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Copeptin: Utility in Paediatric Patients with Hyponatraemia</atitle><jtitle>Hormone research in paediatrics</jtitle><addtitle>Horm Res Paediatr</addtitle><date>2022-05-01</date><risdate>2022</risdate><volume>95</volume><issue>1</issue><spage>82</spage><epage>87</epage><pages>82-87</pages><issn>1663-2818</issn><eissn>1663-2826</eissn><abstract>Introduction: Copeptin concentrations are a useful component of the diagnostic workup of paediatric patients with polyuria and polydipsia, but the value of measuring copeptin in patients with hyponatraemia is less clear. Case Reports: We report 5 children with hyponatraemia in the context of different underlying pathologies. Copeptin concentrations were elevated in 4 cases (13.7, 14.4, 26.1, and 233 pmol/L; reference range 2.4–8.6 pmol/L), suggesting that non-osmoregulated vasopressin release (syndrome of inappropriate antidiuretic hormone) was the underlying mechanism for low sodium levels. In one of the patients, there was an underlying diagnosis of Schaaf-Yang syndrome (MAGEL2 gene mutation) with a clinical picture suggestive of dysregulated vasopressin production with inappropriately high and then low copeptin release. In one hyponatraemic patient, low copeptin concentrations indicated that non-osmoregulated arginine vasopressin release was not the cause of hyponatraemia and oliguria. Discussion: Copeptin measurement did not influence management acutely but helped to clarify the mechanism leading to hyponatraemia when the result was available. Relatively high and low copeptin concentrations in association with hypo- and hypernatraemia indicate dysregulated vasopressin production in Schaaf-Yang syndrome.</abstract><cop>Basel, Switzerland</cop><pmid>34814150</pmid><doi>10.1159/000521073</doi><tpages>6</tpages><orcidid>https://orcid.org/0000-0002-4234-8545</orcidid><orcidid>https://orcid.org/0000-0003-3120-2513</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 1663-2818
ispartof Hormone research in paediatrics, 2022-05, Vol.95 (1), p.82-87
issn 1663-2818
1663-2826
language eng
recordid cdi_pubmed_primary_34814150
source Karger Journals Complete; Alma/SFX Local Collection
subjects Novel Insights from Clinical Practice / Case Report
title Copeptin: Utility in Paediatric Patients with Hyponatraemia
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-19T10%3A34%3A28IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_karge&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Copeptin:%20Utility%20in%20Paediatric%20Patients%20with%20Hyponatraemia&rft.jtitle=Hormone%20research%20in%20paediatrics&rft.au=Boal,%20Rachel%20L.&rft.date=2022-05-01&rft.volume=95&rft.issue=1&rft.spage=82&rft.epage=87&rft.pages=82-87&rft.issn=1663-2818&rft.eissn=1663-2826&rft_id=info:doi/10.1159/000521073&rft_dat=%3Cpubmed_karge%3E34814150%3C/pubmed_karge%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/34814150&rfr_iscdi=true